Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Satellos Bioscience and FSHD Canada Foundation Partner to Fund Phase 2 Trial for Forazapadin in FSHD.
Contract Type
partnership
TorontoBiotechnologyDescription
Satellos Bioscience has partnered with the FSHD Canada Foundation, which committed up to US$5 million in funding for the clinical development of forazapadin targeting facioscapulohumeral muscular dystrophy (FSHD). This collaboration is aimed at advancing treatments in a market lacking approved disease-modifying therapies.
Related People
Agreement Insights
What this usually meansSatellos Bioscience signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.